Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve)
Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve)
The purpose of this clinical research study is to learn if Irbesartan is superior to placebo in reducing mortality and cardiovascular morbidity in subjects with heart failure with preserved systolic function. The safety of this treatment will also be studied.
Inclusion Criteria:
Exclusion Criteria:
Lynchberg, Virginia, United States
Buenos Aires, Buenos Aires, Argentina
Garran, New South Wales, Australia
Genk-waterschei, Belgium
Goiania-go, Goiás, Brazil
Ste-Foy, Quebec, Canada
Copenhagen Nv, Denmark
Homburg / Saar, Germany
County Dublin, Dublin, Ireland
Hengelo Ov, Netherlands
Baerum Postterminal, Norway
Piotrkow Tryb., Poland
Parktown West, Gauteng, South Africa